Evaluating the HER-2 status of breast cancer using mammography radiomics features

被引:39
|
作者
Zhou, Jing [1 ,2 ,4 ]
Tan, Hongna [1 ,2 ]
Bai, Yan [1 ,2 ]
Li, Jie [3 ]
Lu, Qing [1 ,2 ]
Chen, Rushi [1 ,2 ]
Zhang, Menghuan [1 ,2 ]
Feng, Qin [1 ,2 ]
Wang, Meiyun [1 ,2 ]
机构
[1] Henan Prov Peoples Hosp, Dept Radiol, 7 Rd,Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China
[2] Imaging Diag Neurol Dis & Res Lab Henan Prov, Zhengzhou, Henan, Peoples R China
[3] Huiying Med Technol Inc, Beijing, Peoples R China
[4] Mudanjiang Med Univ, Med Imaging Sch, Mudanjiang 157011, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer; HER-2; Radiomics; Mammography; THERAPY;
D O I
10.1016/j.ejrad.2019.108718
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim of our study was to evaluate the HER-2 status in breast cancer patients using mammography (MG) radiomics features. Methods: A total of 306 Chinese female patients with invasive ductal carcinoma of no special type (IDC-NST) enrolled from January 2013 to July 2018 were divided into a training set (n= 244) and a testing set (n= 62). One hundred and eighty-six radiomics features were extracted from digital MG images based on the training set. The least absolute shrinkage and selection operator (LASSO) method was used to select the optimal predictive features for HER-2 status from the training set. Both support vector machine (SVM) and logistic regression models were employed based on the selected features. The area under the receiver operating characteristic (ROC) curves (AUCs) of the training set and testing set were used to evaluate the predictive performance of the models. Results: Compared with the SVM model, the performance of the logistic regression model using a combination of cranial caudal (CC) and mediolateral oblique (MLO) MG views was optimal. In the training set, the sensitivity, specificity, accuracy and area under the curve (AUC) values of the logistic regression model for evaluating HER-2 status based on quantitative radiomics features were 87.29%, 58.73%, 80.00% and 0.846 (95% confidence interval (CI), 0.800-0.887), respectively, and in the testing set, the values were 73.91%, 68.75%, 77.00% and 0.787 (95% CI, 0.673-0.885), respectively. Conclusions: Radiomics features could be an efficient tool for the preoperative evaluation of HER-2 status in patients with breast cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study
    Zhou, Jing
    Yu, Xuan
    Wu, Qingxia
    Wu, Yaping
    Fu, Cong
    Wang, Yunxia
    Hai, Menglu
    Tan, Hongna
    Wang, Meiyun
    HELIYON, 2024, 10 (07)
  • [32] Immunohistochemiluminescence detection: A quantitative tool in breast cancer HER-2 status evaluation
    Barreto de Melo Rego, Moacyr Jesus
    Cordeiro, Marina Ferraz
    Bezerra Cavalcanti, Carmelita de Lima
    de Carvalho Junior, Luiz Bezerra
    Carneiro Beltrao, Eduardo Isidoro
    DISEASE MARKERS, 2013, 34 (05) : 373 - 377
  • [33] Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer
    Hayashi, Naoki
    Iwamoto, Takayuki
    Gonzalez-Angulo, Ana M.
    Ferrer-Lozano, Jaime
    Lluch, Ana
    Niikura, Naoki
    Bartholomeusz, Chandra
    Nakamura, Seigo
    Hortobagyi, Gabriel N.
    Ueno, Naoto T.
    ONCOLOGIST, 2011, 16 (07): : 956 - 965
  • [34] TOP2A Amplification in Breast Cancer in the Absence of That of HER-2: Myth or Reality?
    Lamy, Pierre-Jean
    Jacot, William
    ONCOLOGIST, 2012, 17 (12): : E60 - E61
  • [35] Express Analysis of HER-2/NEU Status in Breast Cancer Biopsy Specimens
    Nechaev, I. N.
    Knyazev, E. N.
    Krainova, N. A.
    Shkurnikov, M. Yu.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 155 (04) : 522 - 526
  • [36] Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancer
    Petersen, Eva Rabing Brix
    Sorensen, Patricia Diana
    Jakobsen, Erik Hugger
    Madsen, Jonna Skov
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (07) : 1483 - 1492
  • [37] Added Value of Radiomics on Mammography for Breast Cancer Diagnosis: A Feasibility Study
    Mao, Ning
    Yin, Ping
    Wang, Qinglin
    Liu, Meijie
    Dong, Jianjun
    Zhang, Xuexi
    Xie, Haizhu
    Hong, Nan
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2019, 16 (04) : 485 - 491
  • [38] HER-2/neu diagnostics in breast cancer
    Carney, Walter P.
    Leitzel, Kim
    Ali, Suhail
    Neumann, Rainer
    Lipton, Allan
    BREAST CANCER RESEARCH, 2007, 9 (03)
  • [39] Clinical significance of Mena and Her-2 expression in breast cancer
    Du, J. W.
    Xu, K. Y.
    Fang, L. Y.
    Qi, X. L.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (05) : 455 - 458
  • [40] HER-2/neu expression in primary and metastatic breast cancer
    Elyse E. Lower
    Eleanor Glass
    Robbin Blau
    Stacy Harman
    Breast Cancer Research and Treatment, 2009, 113 : 301 - 306